Effect of Cold Application on Patient's Pain and Vital Signs During Chest Tube Removal.

Summary

In this study, the effect of cold application used during and after chest tube removal on pain and vital signs in infants and children in the 0-3 age group will be examined.

Conditions

• Chest Tube Removal

Interventions

OTHER

cold application

Oral paracetamol 10 mg/kg, which is administered as standard 60 minutes before the procedure, will be given to patients who have decided to remove the chest tube by the physician and comply with the limitations of the study. After that, initial pain severity and vital signs of the patient will be recorded using FLACC 15 minutes before the start of the chest tube removal process (1.MEASURE). After this measurement, the cold gel package will be wrapped in gauze and placed directly on the skin, covering the area around the chest tube with a radius of about 5 cm. The cold gel package will remain on the skin surface for about 20 minutes. After 15 minutes, the cold package will be removed and the chest tube will be removed by the doctor.

OTHER

cold application until 13.6 C

After measurements, the cold gel package, which rotates with one end open and forms a circle, will be wrapped in gauze and placed directly on the skin in a radius of about 5 cm, covering around the chest tube. 10 of the app. After the minute, the skin temperature will be measured with an infrared thermometer if the heat falls below 13.6 o C, the process will be terminated. If the skin temperature does not fall below 13.6 0 C, the application will continue, the application will be terminated when the heat falls below the specified temperature. After the cold package is removed, the chest tube will be removed by the doctor.

Sponsors & Collaborators

• Muğla Sıtkı Koçman University

  lead OTHER

Principal Investigators

• gonca muslu · Muğla Sıtkı Koçman University

• dilek beytut, PhD · KKTC Lefke Europe University

• saime yıldırım, nurse · Dr. Behçet Uz Child hospital

• recep kara, PhD student · Muğla Sıtkı Koçman University

• figen koyuncu, nurse · Dr. Behçet Uz Child hospital

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

1 Month

Max Age

3 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2026-10-15

Primary Completion

2026-10-15

Completion

2026-10-15

Countries

• Turkey (Türkiye)

Study Locations